STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Ceribell (Nasdaq: CBLL) announced that Jane Chao, Ph.D., CEO and co-founder will present at the Piper Sandler 37th Annual Healthcare Conference in New York on Wednesday, December 3, 2025.

The presentation is scheduled for 6:10 a.m. PST / 9:10 a.m. EST. A live and archived webcast will be available in the Investor Relations section of Ceribell's website at https://investors.ceribell.com/.

Ceribell (Nasdaq: CBLL) ha annunciato che Jane Chao, Ph.D., CEO e co-fondatrice interverrà al Piper Sandler 37th Annual Healthcare Conference a New York mercoledì 3 dicembre 2025.

La presentazione è prevista per le 6:10 AM PST / 9:10 AM EST. Una trasmissione webcast in diretta e registrata sarà disponibile nella sezione Investor Relations del sito di Ceribell all'indirizzo https://investors.ceribell.com/.

Ceribell (Nasdaq: CBLL) anunció que Jane Chao, Ph.D., CEO y cofundadora presentará en la Piper Sandler 37th Annual Healthcare Conference en Nueva York el miércoles 3 de diciembre de 2025.

La presentación está programada para las 6:10 a.m. PST / 9:10 a.m. EST. Una transmisión en vivo y archivada estará disponible en la sección de Relaciones con Inversores del sitio web de Ceribell en https://investors.ceribell.com/.

Ceribell (나스닥: CBLL)Jane Chao, Ph.D., CEO 겸 공동 설립자가 뉴욕에서 열리는 Piper Sandler 37th Annual Healthcare Conference에 발표할 것이라고 발표했습니다 2025년 12월 3일 수요일.

발표는 PST 6:10 a.m. / EST 9:10 a.m.에 예정되어 있습니다. 생중계 및 아카이브 webcast은 Ceribell의 웹사이트 투자자 관계 섹션에서 https://investors.ceribell.com/에서 이용 가능합니다.

Ceribell (Nasdaq : CBLL) a annoncé que Jane Chao, Ph.D., PDG et cofondatrice interviendrait lors de la Piper Sandler 37th Annual Healthcare Conference à New York le mercredi 3 décembre 2025.

La présentation est prévue pour 6:10 a.m. PST / 9:10 a.m. EST. Une diffusion en direct et archivale sera disponible dans la section Relations avec les investisseurs du site de Ceribell à l’adresse https://investors.ceribell.com/.

Ceribell (Nasdaq: CBLL) gab bekannt, dass Jane Chao, Ph.D., CEO und Mitbegründerin auf der Piper Sandler 37th Annual Healthcare Conference in New York am Mittwoch, dem 3. Dezember 2025 auftreten wird.

Die Präsentation ist vorgesehen für 6:10 Uhr PST / 9:10 Uhr EST. Eine Live- und Archiv-Übertragung wird im Bereich Investor Relations der Ceribell-Webseite unter https://investors.ceribell.com/ verfügbar sein.

Ceribell (بورصة ناسداك: CBLL) أعلنت أن جاين تشاو، دكتوراه، الرئيسة التنفيذية والمؤسسة المشاركة ستقدم في المؤتمر الطبي السنوي الثامن والثلاثين لشركة بايبر ساندلر في نيويورك يوم الأربعاء 3 ديسمبر 2025.

من المقرر أن تكون الساعة 6:10 صباحًا بتوقيت المحيط الهادئ / 9:10 صباحًا بتوقيت شرق الولايات المتحدة. سيكون هناك بث حي ومتاح أرشيفيًا عبر الإنترنت في قسم علاقات المستثمرين على موقع Ceribell الإلكتروني على العنوان https://investors.ceribell.com/.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming Piper Sandler 37th Annual Healthcare Conference in New York. The presentation will take place on Wednesday, December 3, 2025, at 6:10 a.m. Pacific Standard Time / 9:10 a.m. Eastern Standard Time. 

Event: Piper Sandler 37th Annual Healthcare Conference
Date: Wednesday, December 3, 2025
Time: 6:10 a.m. PST / 9:10 a.m. EST

A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/

About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for detecting suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.

Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com

Media Contact
Brian Price
Press@ceribell.com


FAQ

When will Ceribell (CBLL) present at the Piper Sandler 37th Annual Healthcare Conference?

Ceribell will present on December 3, 2025 at 6:10 a.m. PST / 9:10 a.m. EST.

Who is presenting for Ceribell (CBLL) at the Piper Sandler conference?

Jane Chao, Ph.D., CEO and co-founder of Ceribell will present.

How can investors watch Ceribell's (CBLL) Piper Sandler presentation?

A live and archived webcast will be available in the Investor Relations section at https://investors.ceribell.com/.

What time is Ceribell's (CBLL) presentation in Eastern Time?

The presentation starts at 9:10 a.m. Eastern Standard Time.

Will Ceribell (CBLL) make the presentation recording available after the event?

Yes, an archived webcast will be posted on Ceribell's Investor Relations website.

What is the focus of Ceribell (CBLL) as described in the announcement?

Ceribell is a medical technology company focused on diagnosis and management of serious neurological conditions.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

506.36M
29.22M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE